Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

The Lancet - United Kingdom
doi 10.1016/s0140-6736(08)61033-8
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Us Burden of Illness Associated With Adjuvant Therapy for Stage I-Iii Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer
Cancer ResearchOncology
2012English

Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial

Haemophilia
MedicineGeneticsHematology
2019English

Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial

Oncotarget
Oncology
2016English

P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology
MedicineOncologyHematology
2014English

Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Association Between Circulating Tumor Cells and Prognosis in Patients With Stage III Melanoma With Sentinel Lymph Node Metastasis in a Phase III International Multicenter Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Prostate Cancer and Hypofractionation: Reflections on Recent Randomised Phase III Clinical Trial Results

Translational Andrology and Urology
Reproductive MedicineUrology
2017English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy